by admin | Oct 11, 2017 | Blog, cancer research, FDA Approvals
US FDA approval for Abemaciclib (Verzenio) ushers in new hope for breast cancer patients Abemaciclib works by blocking the function of two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6. These proteins play a role in driving cell multiplication, which is...
by admin | Jan 24, 2017 | Blog
We are currently under construction. Please check back soon for updates.
Recent Comments